Filter Results
:
(2,322)
Show Results For
-
All HBS Web
(8,226)
- Faculty Publications (2,322)
Show Results For
-
All HBS Web
(8,226)
- Faculty Publications (2,322)
health →
- September 2020
- Case
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,...
View Details
Keywords:
Vaccines;
COVID-19 Pandemic;
Health Pandemics;
Health Testing and Trials;
Innovation and Management;
Innovation Strategy;
Technological Innovation;
Business Strategy;
Product Launch;
Pharmaceutical Industry
Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Case 621-028, September 2020.
- September 2020 (Revised December 2020)
- Case
Siba Mtongana: A Pioneering Chef in South Africa
By: Boris Groysberg, Susan Seligson, Katherine Connolly Baden and Robin Abrahams
For Siba Mtongana, South African celebrity chef, the year 2020 was fraught with challenges and unknowns. Her brand was strong and she was certain it would survive. But as she fine-tuned her growth and innovation strategy in a shaky, unpredictable economy in the midst...
View Details
Keywords:
Food;
Crisis Management;
Health Pandemics;
Growth and Development Strategy;
Food and Beverage Industry;
South Africa
Groysberg, Boris, Susan Seligson, Katherine Connolly Baden, and Robin Abrahams. "Siba Mtongana: A Pioneering Chef in South Africa." Harvard Business School Case 421-026, September 2020. (Revised December 2020.)
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of...
View Details
Keywords:
COVID-19;
High-risk Patients;
Primary Care;
Health Pandemics;
Health Care and Treatment;
Innovation and Invention;
Demographics;
Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).
- September 2020
- Teaching Note
West Side United: Hospitals Tackle the Racial Health and Wealth Gap
By: Rosabeth Moss Kanter and Joyce J. Kim
Teaching Note for HBS Case No. 321-026.
View Details
Keywords:
COVID-19;
COVID;
Hospital;
Coalition;
Health Pandemics;
Race;
Health;
Wealth and Poverty;
Equality and Inequality;
Change;
Leadership;
Chicago
- September 2020 (Revised July 2021)
- Case
Moderna (A)
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman
In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital...
View Details
Keywords:
COVID-19;
Vaccine;
Digital Organizations;
Organizational Structure;
Operations;
Management;
Health Pandemics;
Research and Development;
Goals and Objectives
Iansiti, Marco, Karim R. Lakhani, Hannah Mayer, and Kerry Herman. "Moderna (A)." Harvard Business School Case 621-032, September 2020. (Revised July 2021.)
- September 2020
- Case
Jan Swartz: Steering Princess Cruises Through the COVID-19 Crisis
By: Boris Groysberg and Michael Norris
In the summer of 2020, Jan Swartz, President of Princess Cruises, was persevering to lead her company back from the depths of the COVID-19 Pandemic. Diamond Princess, one of Princess Cruises’ 18 ships was the site of one of the earliest large outbreaks of COVID-19...
View Details
Keywords:
COVID-19 Pandemic;
COVID-19;
Leading Change;
Crisis Management;
Ship Transportation;
Health Pandemics;
Human Resources;
Business Strategy;
Gender;
Personal Development and Career;
Entertainment and Recreation Industry;
Travel Industry;
Tourism Industry;
Japan;
United States
Groysberg, Boris, and Michael Norris. "Jan Swartz: Steering Princess Cruises Through the COVID-19 Crisis." Harvard Business School Case 421-036, September 2020.
- September 2020 (Revised January 2021)
- Case
Catalys Pacific
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After...
View Details
Keywords:
Pharmaceutical Companies;
Biotech;
Health Care;
Entrepreneur;
Innovation;
International Business;
Entrepreneurial Finance;
Entrepreneurship;
Finance;
Innovation Strategy;
Venture Capital;
Strategy;
Cross-Cultural and Cross-Border Issues;
Pharmaceutical Industry;
Biotechnology Industry;
Tokyo
Krieger, Joshua Lev. "Catalys Pacific." Harvard Business School Case 821-035, September 2020. (Revised January 2021.)
- September 8, 2020
- Article
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level...
View Details
Kakani, Pragya, Amitabh Chandra, and Sendhil Mullainathan. "Allocation of COVID-19 Relief Funding to Disproportionately Black Counties." JAMA, the Journal of the American Medical Association 324, no. 10 (September 8, 2020): 1000–1003.
- 8 Sep 2020
- Interview
The U.S. Health Care System: From Dysfunction to Functioning
By: Regina E. Herzlinger and Edward Shin
Herzlinger, Regina E., and Edward Shin. "The U.S. Health Care System: From Dysfunction to Functioning." Q-Reviews (podcast), Quality Reviews, Inc., September 8, 2020.
- September 2020 (Revised February 2021)
- Case
Zameer Kassam Fine Jewelry: Engaging Clients
By: Ryan W. Buell and Amy Klopfenstein
Zameer Kassam Fine Jewelry (ZKFJ) designs custom engagement rings that tell the story of a couple’s relationship. The case describes the company’s process for engaging clients, which has historically been a relatively offline, high-touch experience. Obliged by...
View Details
Keywords:
Customer Engagement;
Service Delivery;
Health Pandemics;
Internet and the Web;
Customer Satisfaction;
Organizational Change and Adaptation;
Growth and Development;
Retail Industry
Buell, Ryan W., and Amy Klopfenstein. "Zameer Kassam Fine Jewelry: Engaging Clients." Harvard Business School Case 621-043, September 2020. (Revised February 2021.)
- 2024
- Working Paper
Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the...
View Details
Keywords:
Immunotherapy;
Health Care and Treatment;
Innovation and Invention;
Research and Development;
Governing Rules, Regulations, and Reforms
Bhidé, Amar, and Srikant M. Datar. "Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-035, August 2020. (Revised May 2024.)
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our...
View Details
Keywords:
Health Insurance;
Public Option;
Health Care and Treatment;
Insurance;
Cost Management;
United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- Article
Get Ready to Sell
By: Frank V. Cespedes and Bud Hyler
Time-to-market measures the time to have a product ready to ship. But that’s not revenue and cash. Many firms with superb R&D functions lack an understanding of what’s needed to be ready-to-sell. Meanwhile, relevant tools are increasing in scope and decreasing in cost....
View Details
Cespedes, Frank V., and Bud Hyler. "Get Ready to Sell." Top Sales Magazine (September 2020), 32–33.
- September–October 2020
- Article
Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How.
By: Willy C. Shih
The COVID-19 pandemic exposed the vulnerabilities in the production strategies and supply chains of firms everywhere. Coupled with a rise in economic nationalism, manufacturers everywhere are going to be under pressure to rethink their sourcing and logistics...
View Details
Keywords:
Resilience;
Pandemic;
Operations Management;
Health Pandemics;
Supply Chain;
Supply Chain Management;
Manufacturing Industry;
United States;
Asia;
Europe
Shih, Willy C. "Global Supply Chains in a Post-Pandemic World: Companies Need to Make Their Networks More Resilient. Here's How." R2005F. Harvard Business Review 98, no. 5 (September–October 2020): 82–89.
- September 2020
- Article
Regulatory Sandboxes: A Cure for mHealth Pilotitis?
By: Abhishek Bhatia, Rahul Matthan, Tarun Khanna and Satchit Balsari
Mobile health (mHealth) and related digital health interventions in the past decade have not always scaled globally as anticipated earlier despite large investments by governments and philanthropic foundations. The implementation of digital health tools has suffered...
View Details
Keywords:
COVID-19;
mHealth;
Digital Health;
Design Thinking;
Regulation;
Intervention;
Regulatory Sandbox;
Health Care and Treatment;
Technological Innovation;
Design;
Governing Rules, Regulations, and Reforms;
India
Bhatia, Abhishek, Rahul Matthan, Tarun Khanna, and Satchit Balsari. "Regulatory Sandboxes: A Cure for mHealth Pilotitis?" Journal of Medical Internet Research 22, no. 9 (September 2020).
- September–October 2020
- Article
The Past, Present, and (Near) Future of Gene Therapy and Gene Editing
By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused...
View Details
Keywords:
Gene Therapy;
Gene Editing;
Impact;
Health Care and Treatment;
Technological Innovation;
Health Testing and Trials;
Venture Capital;
Change
Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).
- September 2020
- Article
Unequal Effects of the COVID-19 Pandemic on Scientists
By: Kyle Myers, Wei Yang Tham, Yian Yin, Nina Cohodes, Marie Thursby, Jerry Thursby, Peter Schiffer, Joseph Walsh, Karim R. Lakhani and Dashun Wang
COVID-19 has not affected all scientists equally. A survey of principal investigators indicates that female scientists, those in the ‘bench sciences’ and, especially, scientists with young children experienced a substantial decline in time devoted to research. This...
View Details
Myers, Kyle, Wei Yang Tham, Yian Yin, Nina Cohodes, Marie Thursby, Jerry Thursby, Peter Schiffer, Joseph Walsh, Karim R. Lakhani, and Dashun Wang. "Unequal Effects of the COVID-19 Pandemic on Scientists." Nature Human Behaviour 4, no. 9 (September 2020): 880–883.
- 2020
- Working Paper
Venture Capitalists and COVID-19
By: Paul A. Gompers, Will Gornall, Steven N. Kaplan and Ilya A. Strebulaev
We survey over 1,000 institutional and corporate venture capitalists (VCs) at more than 900 different firms to learn how their decisions and investments have been affected by the COVID-19 pandemic. We compare their survey answers to those provided by a large sample of...
View Details
Gompers, Paul A., Will Gornall, Steven N. Kaplan, and Ilya A. Strebulaev. "Venture Capitalists and COVID-19." NBER Working Paper Series, No. 27824, September 2020.
- August 2020
- Case
Sangu Delle
By: Leslie Perlow and Matthew Preble
By 2020, Sangu Delle (MBA 2016) has already made significant progress towards his life-long goal of solving Africa’s myriad and diverse challenges. At 33 years old, he is the founder and chairman of the for-profit Golden Palm Investments Corporation, CEO of Africa...
View Details
Keywords:
Impact;
Impact Investing;
Mental Health;
Social Capitalism;
Entrepreneurship;
Investment;
Health Care and Treatment;
Personal Development and Career;
Health Industry;
Africa
Perlow, Leslie, and Matthew Preble. "Sangu Delle." Harvard Business School Case 421-031, August 2020.
- August 2020 (Revised December 2020)
- Case
Latam Airlines and COVID-19: Seeking Bankruptcy Protection in the United States
By: Laura Alfaro, Mauricio Larrain, Carlos Vilches and Sarah Jeong
On May 26, 2020, Latam Airlines became the largest airline in the world to be driven to bankruptcy by COVID-19. With a complex debt structure and international investor composition, the company decided to file for bankruptcy protection in the United States, which...
View Details
Keywords:
Airlines;
Pandemic;
Coronavirus Pandemic;
Health Pandemics;
Air Transportation;
Insolvency and Bankruptcy;
Capital Markets;
Strategy;
Latin America;
Chile;
United States
Alfaro, Laura, Mauricio Larrain, Carlos Vilches, and Sarah Jeong. "Latam Airlines and COVID-19: Seeking Bankruptcy Protection in the United States." Harvard Business School Case 321-027, August 2020. (Revised December 2020.)